Clinical research jobs and magazine for the UK

Home

This Month

Archives

Free Subscription

Links

Jobs

Contact

07 September 2010

Site Search

Featured Advertisers

News
University leads major new research into wound care 17 September 2009 The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.
Greece cuts prices of over 4,000 drugs by 20% Greece cuts prices of over 4,000 drugs by 20% Elan gets injunction to stop dissident directors Elan gets injunction to stop dissident directors Read more...

Issue 4: Oct/Dec 2006

Simplifying the Application Process: A Look at the COREC Form
In April 2004 COREC launched a standard NHS REC application form. This initiative anticipated the introduction of European Directive on Clinical Trials (2001/20/EC) in May 2004 and provided appli ...

Clinical trials in diabetes: challenges in patient recruitment
Diabetes is one of the largest therapeutic areas in terms of global pharmaceutical sales. During the last 10 years, the market has grown by a compound average growth rate of nearly 20% from around ...

Pharmacovigilance in Clinical Trials of Investigational Medicinal Products
Pharmacovigilance is regarded as a problem for non-commercial sponsors principally because the Medicines for Human Use Regulations (2004) required a major change in systems and processes from thos ...

Re: Applying an Integrated Approach
A letter to the editor of Clinical Discovery on the integrated approach to R&D approvals.

Research Management & Governance in Wales - the way FORWARD
FORWARD is a specialist support service in Research Management & Governance and is part of Clinical Research Collaboration Cymru (CRC Cymru), the new R&D infrastructure for health and social care ...

Pharma-Biotech Alliances - the Answer to Pharma's Pipeline Problems?
Big pharma is at a stage where it needs to re-invent itself. The current situation prevailing in big pharma is unsustainable, as these companies are spending increasingly more on R&D while, at the ...